These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 2919600

  • 1. Phosphate-binding effects of sucralfate in patients with chronic renal failure.
    Roxe DM, Mistovich M, Barch DH.
    Am J Kidney Dis; 1989 Mar; 13(3):194-9. PubMed ID: 2919600
    [Abstract] [Full Text] [Related]

  • 2. Aluminium hydroxide versus sucralfate as a phosphate binder in uraemia.
    Leung AC, Henderson IS, Halls DJ, Dobbie JW.
    Br Med J (Clin Res Ed); 1983 Apr 30; 286(6375):1379-81. PubMed ID: 6404468
    [Abstract] [Full Text] [Related]

  • 3. Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients.
    Janssen MJ, van der Kuy A, ter Wee PM, van Boven WP.
    Clin Nephrol; 1996 Feb 30; 45(2):111-9. PubMed ID: 8846523
    [Abstract] [Full Text] [Related]

  • 4. Serum phosphate, parathyroid hormone and vitamin D metabolites in patients with chronic renal failure: effect of aluminum hydroxide administration.
    Takamoto S, Onishi T, Morimoto S, Imanaka S, Tsuchiya H, Seino Y, Yokokawa T, Iida N, Kumahara Y.
    Nephron; 1985 Feb 30; 40(3):286-91. PubMed ID: 3839293
    [Abstract] [Full Text] [Related]

  • 5. Aluminum accumulation during treatment with aluminum hydroxide and dialysis in children and young adults with chronic renal disease.
    Salusky IB, Foley J, Nelson P, Goodman WG.
    N Engl J Med; 1991 Feb 21; 324(8):527-31. PubMed ID: 1992306
    [Abstract] [Full Text] [Related]

  • 6. Calcium carbonate as a phosphate binder in dialysis patients: evaluation of an enteric-coated preparation and effect of additional aluminium hydroxide on hyperaluminaemia.
    Ittel TH, Schäfer C, Schmitt H, Gladziwa U, Sieberth HG.
    Klin Wochenschr; 1991 Jan 22; 69(2):59-67. PubMed ID: 2027271
    [Abstract] [Full Text] [Related]

  • 7. Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing dialysis.
    Slatopolsky E, Weerts C, Lopez-Hilker S, Norwood K, Zink M, Windus D, Delmez J.
    N Engl J Med; 1986 Jul 17; 315(3):157-61. PubMed ID: 3724805
    [Abstract] [Full Text] [Related]

  • 8. Effectiveness of aluminum hydroxide timing administration in relation to meals in controlling hyperphosphatemia in dialysis patients.
    Katopodis KP, Andrikos E, Pappas M, Siamopoulos KC.
    Int J Artif Organs; 2005 Aug 17; 28(8):803-7. PubMed ID: 16211530
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of long-term treatment with calcium carbonate as a phosphate binder.
    Malberti F, Surian M, Poggio F, Minoia C, Salvadeo A.
    Am J Kidney Dis; 1988 Dec 17; 12(6):487-91. PubMed ID: 3143260
    [Abstract] [Full Text] [Related]

  • 10. Antacid and sucralfate-induced hypophosphatemic osteomalacia: a case report and review of the literature.
    Chines A, Pacifici R.
    Calcif Tissue Int; 1990 Nov 17; 47(5):291-5. PubMed ID: 2257522
    [Abstract] [Full Text] [Related]

  • 11. Substitution of calcium carbonate for aluminum hydroxide in patients on hemodialysis. Effects on acidosis, on parathyroid function, and on calcemia.
    Anelli A, Brancaccio D, Damasso R, Padovese P, Gallieni M, Garella S.
    Nephron; 1989 Nov 17; 52(2):125-32. PubMed ID: 2500612
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The use of calcium carbonate to treat the hyperphosphataemia of chronic renal failure.
    Williams B, Vennegoor M, O'Nunan T, Walls J.
    Nephrol Dial Transplant; 1989 Nov 17; 4(8):725-9. PubMed ID: 2510082
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.